title: Erratum to: Establishing medical plausibility in the context of orphan medicines designation in the European Union.
authors.affiliation: Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. Stylianos.Tsigkos@ema.europa.eu.
authors.forename: Stelios
authors.initials: S
authors.lastname: Tsigkos
authors.affiliation: Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. segundo.mariz@ema.europa.eu.
authors.forename: Segundo
authors.initials: S
authors.lastname: Mariz
authors.affiliation: Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. jordi.llinares@ema.europa.com.
authors.forename: Jordi
authors.initials: J
authors.lastname: Llinares
authors.affiliation: Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. laura.fregonese@ema.europa.eu.
authors.forename: Laura
authors.initials: L
authors.lastname: Fregonese
authors.affiliation: Orphan Medicines Office, European Medicines Agency, 7 Westferry Circus, Canary Wharf, London, E144HB, UK. stiina.aarum@ema.europa.eu.
authors.forename: Stiina
authors.initials: S
authors.lastname: Aarum
authors.affiliation: Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger-Allee 3, Bonn, 53175, Germany. Frauke.Naumann-Winter@bfarm.de.
authors.forename: Frauke
authors.initials: F
authors.lastname: Naumann-Winter
authors.affiliation: Läkemedelsverket, Dag Hammarskjölds vägen 42, Uppsala, 75103, Sweden. kerstin.westermark@mpa.se.
authors.forename: Kerstin
authors.initials: K
authors.lastname: Westermark
authors.affiliation: Research Institute for Medicines (iMED.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisboa, 1649-003, Portugal. bruno.sepodes@ema.europa.eu.
authors.forename: Bruno
authors.initials: B
authors.lastname: Sepodes